Peijia MedicalPEJMF 76 EBITDA Margin % is -26.12% as of Dec. 2025. GuruFocus rates PEJMF with a GF Score™ of 76/100 and a GF Value™ of $2.75. The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Peijia Medical ranks worse than 71.2% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Peijia Medical's EBITDA for the
six
months ended in Dec. 2025 was $-13.3 Mil. Peijia Medical's Revenue for the
six
months ended in Dec. 2025 was $51.0 Mil. Therefore, Peijia Medical's EBITDA margin for the quarter that ended in Dec. 2025 was -26.12%.
Peijia Medical (OTCPK:PEJMF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Peijia Medical EBITDA Margin % Related Terms
Peijia Medical EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Peijia Medical's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PEJMF vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Peijia Medical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Peijia Medical EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Peijia Medical's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Peijia Medical's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Peijia Medical (PEJMF) has a EBITDA Margin % of -26.12% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Peijia Medical and its competitors. According to the industry distribution chart, Peijia Medical ranks #581 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 71.2%.
Is Peijia Medical's EBITDA Margin % too high?
Peijia Medical's current EBITDA Margin % is -26.12%. Based on the distribution chart, Peijia Medical ranks #581 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Peijia Medical has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Peijia Medical's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Peijia Medical ranks #581 out of 816 companies for EBITDA Margin %. This places Peijia Medical in the lower half of its industry. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Peijia Medical and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peijia Medical's current EBITDA Margin % is -26.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peijia Medical stock overvalued right now?
Peijia Medical (PEJMF) has a current EBITDA Margin % of -26.12%. The stock's GF Value™ is $2.75, compared to a current price of $1.39 — trading 49.6% below its estimated fair value. The current EBITDA Margin % is -26.12%. Peijia Medical's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Peijia Medical (PEJMF), the current EBITDA Margin % is -26.12% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Peijia Medical (PEJMF) Overvalued in 2026?
Based on GuruFocus' analysis, Peijia Medical stock appears to be undervalued.
The current stock price of $1.39 is trading 49.6% below its estimated GF Value™ of $2.75.
Key valuation signals for PEJMF:
EBITDA Margin %: -26.12%
GF Value™: $2.75 vs. price of $1.39 (49.6% below fair value)
No single metric tells the full story. See the PEJMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Peijia Medical Ltdis a provider of inventive medical products and solutions. It focuses on the high-growth interventional procedural medical device market in China. Its products and product candidates target large, fast-growing and under-penetrated markets with high entry barriers, including the transcatheter valve therapeutic medical device market and the neurointerventional procedural medical device market. The Company's product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates spanning three key business segments: Transcatheter Valve Therapeutic Business, Future Technology Business and Neurointerventional Business.
76GF Score
Get the complete analysis for PEJMF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PEJMF has been successfully added to your 
